Articles dans des revues avec comité de lecture (7)
  1. 1. Ando, K., De Decker, R., Vergara Panos, C., Yilmaz, Z., Mansour, S., Suain, V., Sleegers, K., De Fisenne, M.-A., Houben, S., Potier, M.-C., Duyckaerts, C., Watanabe, T., Buée, L., Leroy, K., & Brion, J. P. (2020). Picalm reduction exacerbates tau pathology in a murine tauopathy model. Acta Neuropathologica, 139(4), 773-789. doi:10.1007/s00401-020-02125-x
  2. 2. Lidón, L., Vergara Panos, C., Ferrer, I. S., Hernández, F., Ávila, J., del Río, J. A., & Gavín, R. (2020). Tau Protein as a New Regulator of Cellular Prion Protein Transcription. Molecular neurobiology. doi:10.1007/s12035-020-02025-x
  3. 3. Poncelet, L., Ando, K., Vergara Panos, C., Mansour, S., Suain, V., Yilmaz, Z., Reygel, A., Gilissen, E., Brion, J. P., & Leroy, K. (2019). A 4R tauopathy develops without amyloid deposits in aged cat brains. Neurobiology of aging, 81, NBA10594, 200-212. doi:10.1016/j.neurobiolaging.2019.05.024
  4. 4. Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Vanden Dries, V., Boom, A., Mansour, S., Leroy, K., Ando, K., & Brion, J. P. (2019). Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathologica, 137(3), 397-412. doi:10.1007/s00401-018-1953-5
  5. 5. Mauguière, F., Trejo, J. L., Andjus, P., Vergara Panos, C., & Pochet, R. (2019). Ten priorities for national brain and mental health plans. Croatian medical journal, 60(2), 152-155. doi:10.3325/cmj.2019.60.152
  6. 6. Matamoros-Angles, A., Gayosso, L. M., Richaud-Patin, Y., di Domenico, A. A., Vergara Panos, C., Hervera, A., Sousa, A., Fernández-Borges, N., Consiglio, A., Gavín, R., López de Maturana, R., Ferrer, I. S., López de Munain, A. A., Raya, A., Castilla, J., Sánchez-Pernaute, R., & del Río, J. A. (2018). iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology. Molecular neurobiology, 55(4), 3033-3048. doi:10.1007/s12035-017-0506-6
  7. 7. Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara Panos, C., Belkouch, M., Potier, M.-C., Duyckaerts, C., & Brion, J. P. (2016). Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Neurobiology of disease, 94, 32-43. doi:10.1016/j.nbd.2016.05.017
    8.   Communications publiées lors de congrès ou colloques nationaux et internationaux (4)
  8. 1. Poncelet, L., Ando, K., Vergara Panos, C., Gilissen, E., Brion, J. P., & Leroy, K. (2018). Old cats : a naturally occuring model of tauopathy. Frontiers in Neuroscience Belgian Brain Conference 2018(2018-10-19: Liège) doi:10.3389/conf.fnins.2018.95.00007
  9. 2. Ando, K., Pregoni, G., Verheijen, J., Vergara Panos, C., De Decker, R., Mansour, S., Yilmaz, Z., Suain, V., Dauphinot, L., Fontaine, G., Leroy, K., Duyckaerts, C., Sleegers, K., Potier, M.-C., & Brion, J. P. (2018). PICALM susceptible loci and the levels of its mRNA and protein expression. 2nd EUROtau meeting abstract book 2nd EUROtau meeting(2: 26-27 April 2018: Lille, France)
  10. 3. Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara Panos, C., Belkouch, M., Potier, M.-C., Duyckaerts, C., & Brion, J. P. (2016). Clathrin adaptor CALM/PICALM is involved in tau pathology in Alzheimer and other tauopathies. Front. Aging Neurosci. Vol. 17 6th Belgian Brain Congress.(6: 2016-10-08: Mons). doi:10.3389/conf.fnagi.2016.03.00017
  11. 4. Vergara Panos, C., Houben, S., Vanden Dries, V., Yilmaz, Z., Suain, V., De Decker, R., Duyckaerts, C., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2016). PHF-tau propagation in the presence of Amyloid ß pathology. Front. Aging Neurosci. (p. 219818) 6TH BELGIAN BRAIN CONGRESS(6: 2016-10-08: Mons, Belgium). doi:10.3389/conf.fnagi.2016.03.00017
    12.   Participations à des congrès et colloques internationaux (17)
  12. 1. Ando, K., De Decker, R., Vergara Panos, C., Yilmaz, Z., Mansour, S., Suain, V., Slegers, K., De Fisenne, M.-A., Houben, S., Potier, M.-C., Duyckaerts, C., Watanabe, T., Buée, L., Leroy, K., & Brion, J. P. (2021). Picalm reduction exacerbates tau pathology in a murine tauopathy model. (p. 77, Poster 04) Abstract session presented at  New Horizons in Alzheimer’s Disease(October 27-28, 2021: Leuven, Belgium).
    13. << Précédent 1 2 3 Suivant >>